Department of Pediatric Urology, Seoul National University Children's Hospital, Seoul, Korea.
Int Neurourol J. 2013 Sep;17(3):139-44. doi: 10.5213/inj.2013.17.3.139. Epub 2013 Sep 30.
In pediatric patients with enuresis, the protocol for salvage therapy in patients in whom first-line therapy was not successful has not yet been established. Interferential electrical stimulation (IF-ES) therapy is advantageous because it is noninvasive and shows high compliance. We aimed to investigate the efficacy and safety of IF-ES therapy on pediatric enuresis in a pilot study.
We investigated 10 patients who underwent IF-ES therapy between August 2012 and March 2013 at our clinic. Patients with a history of previous treatment with desmopressin and anticholinergic agents for at least 3 months and those in whom alarm treatment previously failed or was refused by parents were eligible. Electrical current was given starting at approximately 20 mA and was increased until the patient complained of discomfort. Treatment was performed once a week, 20 minutes per treatment, 6 times per cycle. After each cycle, an interview was performed and voiding diaries were filled. The physician in charge evaluated improvement according to the International Children's Continence Society criteria.
A final analysis was performed in 10 patients (5 male and 5 female patients) in whom therapy for nocturnal enuresis had failed. Eight patients had nonmonosymptomatic enuresis and 2 had monosymptomatic enuresis. The mean age of the patients was 8.5±2.4 years, and the mean number of treatments was 10.6±3.6 times. A full response was observed in 1 patient (10%); a good response, in 1 patient (10%); a partial response, in 7 patients (70%); and no response, in 1 patient (10%).
Our study demonstrated that IF-ES therapy can be a promising treatment for the future, is safe, and can benefit from appropriate clinical trials in carefully selected groups. IF-ES therapy is expected to be a safe and effective treatment modality for children with enuresis.
在遗尿症的儿科患者中,对于一线治疗无效的患者,尚未确定挽救治疗方案。干扰电刺激(IF-ES)治疗具有优势,因为它是非侵入性的,并且具有较高的顺应性。我们旨在通过一项初步研究调查 IF-ES 治疗小儿遗尿症的疗效和安全性。
我们调查了 2012 年 8 月至 2013 年 3 月期间在我们诊所接受 IF-ES 治疗的 10 名患者。符合条件的患者包括有使用去氨加压素和抗胆碱能药物治疗至少 3 个月的病史,以及先前的警报治疗失败或被父母拒绝的患者。电流从大约 20 mA 开始给予,并增加到患者感到不适为止。每周治疗一次,每次治疗 20 分钟,一个周期 6 次。每次周期后进行一次访谈并填写排尿日记。主管医生根据国际儿童尿控协会标准评估改善情况。
在 10 名夜间遗尿症治疗失败的患者(5 名男性和 5 名女性患者)中进行了最终分析。8 名患者为非单一症状性遗尿症,2 名患者为单一症状性遗尿症。患者的平均年龄为 8.5±2.4 岁,平均治疗次数为 10.6±3.6 次。1 名患者(10%)完全缓解;1 名患者(10%)有良好的反应;7 名患者(70%)有部分反应;1 名患者(10%)无反应。
我们的研究表明,IF-ES 治疗可能是未来有前途的治疗方法,安全且可以在精心挑选的患者组中进行适当的临床试验受益。IF-ES 治疗有望成为遗尿症儿童安全有效的治疗方法。